---
layout: post
title: "Grant of Interim Extension of the Term of U.S. Patent No. 7,319,099; Bitopertin (GlyT1 inhibitor) Oral Tablets"
date: 2026-02-04 21:37:03 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-22424
original_published: 2025-12-10 00:00:00 +0000
significance: 8.00
---

# Grant of Interim Extension of the Term of U.S. Patent No. 7,319,099; Bitopertin (GlyT1 inhibitor) Oral Tablets

**Published:** February 04, 2026 21:37 UTC
**Source:** Federal Register
**Original Published:** December 10, 2025 00:00 UTC
**Document Number:** 2025-22424

## Summary

The United States Patent and Trademark Office has issued a certificate under 35 U.S.C. 156(d)(5) for a one-year interim extension of the term of U.S. Patent No. 7,319,099 ('099 patent).

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/12/10/2025-22424/grant-of-interim-extension-of-the-term-of-us-patent-no-7319099-bitopertin-glyt1-inhibitor-oral)
- API: https://www.federalregister.gov/api/v1/documents/2025-22424

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
